© science photo / Fotolia
Pharmacelsus
In vitro ADME Services
The in vitro ADME team of Pharmacelsus combines professionalism of the pharmaceutical industry with the flexibility to adapt standard assays for your specific challenges. We use a consultative approach to set-up tailor-made assays together with you. Studies are conducted to meet regulatory requirements.
Evaluate the “druggability” of your compounds by the following set of in vitro ADME assays.
Physico-chemical Parameters
- Chemical stability
- Aqueous solubility
Stability in Biological Matrices
- Blood
- Plasma
- Intestinal fluids
- Further matrices on request
- All preclinical species available
Membrane Permeability
- PAMPA
- Artificial BBB
- Bidirectional Caco2
- PgP interaction
- Nuclear uptake
Interaction with Drug Transporters*
- ABC-ATP binding
- SLC transporters: inhibition/uptake
- PgP interaction
*in cooperation
Protein Binding Mechanism
- PPB (crossfiltration or Rapid Equilibrium Dialysis)
- SPB (crossfiltration or Rapid Equilibrium Dialysis)
- Blood partitioning
- Microsomal binding
Brain Tissue Binding
- Rat, mice tissue
- Ultrafiltration
- Rapid Equilibrium Dialysis
Metabolic Stability
- Liver or intestinal microsomes
- Liver or intestinal S9 fraction
- Hepatocytes
- All preclinical species available
Reactive Metabolite Trapping
- Liver microsomes
- GSH
Metabolite Identification
- Liver or intestinal microsomes
- Liver or intestinal S9 fraction
- Hepatocytes
- Metabolic pathway
CYP Inhibition
- Recombinant human CYPs
- IC50 determination
- Human liver microsomes*
- Mode of inhibition, inhibition kinetics
*according to EMA/FDA Guidelines
CYP Induction
- Hepa RG®
- Human hepatocytes
- Functional activity
- mRNA
CYP Phenotyping
- Recombinant human CYPs
- Loss of parent compound
- Clint
- Half-life
- Formation of major Phase 1 metabolites and metabolic pathway elucidation
Further assays are available on request. All assays can be tailored to project´s requirements and offered in a fit for screening format.
Please contact us for your specific ADME study!
MUDr. Maria Li
Director Business Development
li@pharmacelsus.de
Dr. Julia Przibilla
Team Manager ADMET & in vitro Pharmacology
przibilla@pharmacelsus.de